Maxwell Snead, MD
Ophthalmology · Concord, NHNPI 1053369322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $161 and has fallen 71.2% since, to $46 in 2024. That places this record below the midpoint for ophthalmology clinicians in NH, where the typical reported total is $750.
Across 17 payments — averaging $23.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$94
- Bausch & Lomb, A Division Of Bausch Health US, LLC$85
- Optovue, Inc.$63
- Alcon$61
- AbbVie$43
- Shire North American Group Inc$19
- plus $31 from 2 others
What the payments were for
- Food & beverage$397100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 4 | $94 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $85 |
| Optovue, Inc. | 1 | $63 |
| Alcon | 3 | $61 |
| AbbVie | 2 | $43 |
| Shire North American Group Inc | 1 | $19 |
| Omeros Corporation | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
How this compares
$397 in reported general payments places this provider in the 35th percentile of 80 ophthalmology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 44 | $4,678 |
| Prednisolone Acetate | 108 | $3,660 |
| Travoprost | 23 | $2,114 |
| Latanoprost | 212 | $1,604 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 18 | $1,341 |
| Timolol Maleate | 34 | $954 |
| Ofloxacin | 96 | $857 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $223 |
| Brimonidine Tartrate | 20 | $127 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Concord
- Christie MorseConcord$6K
- Erin FogelConcord$4K
- Jerome Ramos-EstebanConcord$3K
- Tighe RichardsonConcord$2K
- Purvi ShahConcord$638
- Catherine MarandoConcord$288
- Brett SmithConcord$237
- Bradford HallConcord$202
- Dane SlentzDerry$127K
- Jason SzelogPortsmouth$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.